| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10485976 | Value in Health | 2016 | 6 Pages |
Abstract
Testing significantly affected adjuvant treatment in T3 MMR-P stage II colon cancer in clinical practice. The study is limited by its design, which compared treatment recommendations pretesting to actual treatments received post-testing, lack of a control group, and nonassessment of confounding factors that may have affected treatment decisions.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Baruch MD, Ravit MD, Megan PhD, Alexander MD, Ygael MD, Mariana MD, Ayala MD, Efraim MD, PhD, Alexander MD, Ofer MD, Einat MD, Katerina MD, Moshe MD, Sophia MD, Lior PhD, Haluk MD, Calvin MD, Adi MD, Nicky MD,